Literature DB >> 6366565

Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.

H Wesseling, S Agoston, G B Van Dam, J Pasma, D J DeWit, H Havinga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6366565     DOI： 10.1056/NEJM198404123101514

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1990-04-28

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 3.  Recent research on the causes of Alzheimer's disease.

Authors:  I J Deary; L J Whalley
Journal:  BMJ       Date:  1988-10-01

Review 4.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

5.  The influence of aminopyridines on Ca2+-dependent evoked release of acetylcholine from rat cortex slices.

Authors:  F F Foldes; N Ludvig; H Nagashima; E S Vizi
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

6.  Studies of aluminum neurobehavioral toxicity in the intact mammal.

Authors:  R A Yokel; D D Allen; J J Meyer
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

Review 7.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

8.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors.

Authors:  C Peterson; J E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 9.  Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy).

Authors:  Andrew D Goodman; Robert Thompson Stone
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

10.  In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease.

Authors:  Shereen K Ali; Ahmed R Hamed; Maha M Soltan; Usama M Hegazy; Esameldin E Elgorashi; Ibrahim A El-Garf; Ahmed A Hussein
Journal:  BMC Complement Altern Med       Date:  2013-05-30       Impact factor: 3.659
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.